Senegal

in page functions
[French]
Total population (2014) 14,548,171
Birth cohort (2014) 543,033
Surviving Infants (surviving to 1 year per year, 2014) 516,993
Infant mortality rate (deaths < 1 year per 1000 births, 2013) 44/1000
Child mortality rate (deaths < 5 years per 1000 births, 2013) 55/1000
World Bank Index, IDA (2012) 3.68
Gross Nation Income (per capita US$, 2012) 1,040
Co-financing status (2013) Intermediate
No. of districts/territories (2013) 76

Gavi support for Senegal

Type of support

Approvals

2001-2020 (US$)
(30 Sep 2014)

Commitments

2001-2020 (US$)
(30 Sep 2014)

Disbursements

2000-2014 (US$)
(30 Sep 2014)

% Disbursed

(30 Sep 2014)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $3,585,500 $3,585,500 $3,585,500 100%
HepB mono (NVS) $588,743 $588,743 $588,743 100%
HPV Demo (NVS) $146,500 $146,500 $75,301 51%
Immunisation services support (ISS) $2,605,740 $2,605,740 $2,605,740 100%
Injection safety support (INS) $619,474 $619,474 $619,474 100%
IPV (NVS) $1,384,500 $2,504,500 $91,180 7%
Measles (NVS) $543,500 $890,500 $221,169 41%
Measles-Rubella (NVS) $4,751,997 $4,751,997 $4,495,177 95%
Meningitis A - campaign (NVS) $2,670,736 $2,670,736 $2,670,736 100%
Meningitis A - operational costs (OPC) $2,567,107 $2,567,107 $2,567,107 100%
MR - Operational costs (OPC) $4,158,500 $4,158,500 $4,158,500 100%
Penta (NVS) $43,857,365 $43,857,365 $38,389,019 88%
Pneumo (NVS) $20,880,775 $28,025,775 $16,346,222 78%
Rotavirus (NVS) $3,607,500 $6,192,000 $1,264,426 35%
Vaccine Introduction Grant (VIG) $2,202,000 $2,202,000 $1,761,000 80%
Total $94,314,937 $105,536,437 $79,584,294

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence


N/A
DTP3 - Official country estimates (2013) 92%
M:F sex ratio at birth (2014) 1.04
Household survey: DTP3 coverage for male (2013) 88.90%
Household survey: DTP3 coverage for female (2013) 88.10%
Household survey: Last DTP3 survey (2013) 89%
% districts achieving > 80% DTP3 coverage (2013) 32%
% districts achieving < 50% DTP3 coverage (2013) 18%
MCV WHO/UNICEF estimates (2013) 84%
Polio WHO/UNICEF estimates (2013) 89%

Breakdown of support

Non-vaccine support Vaccine support
19% 81%
$15,018,821 $64,141,969

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

28 November 2014

Senegal rotavirus launch PM Harper

Senegalese children getting a healthy start in life

One year on from the pneumococcal vaccine launch Senegal introduces the rotavirus vaccine, helping counter the deadly toll of pneumonia and diarrhoea.

28 November 2014

Senegal rotavirus launch

Canada commits C$ 500 million to support immunisation in developing countries

New pledge at the Francophonie Summit will help protect millions of children from deadly diseases.

12 November 2014

WPD2012

Record numbers of children protected against leading causes of pneumonia with Gavi support

“la Caixa” Foundation announces further €1m commitment to support pneumococcal vaccine

close icon

modal window here